News

Press Release | December 4, 2019

ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases

Press Release | November 8, 2019

Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting

Press Release | November 6, 2019

Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting

Press Release | October 28, 2019

Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting

News | October 23, 2019

Novartis bets $80M on Pliant’s preclinical NASH prospect

News | July 19, 2019

Pyxis Oncology Raises $22 Million Series A

News | July 16, 2019

Genentech inks its latest discovery deal — this time turning to RNA upstart Skyhawk

News | July 8, 2019

Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster of partners out to drug RNA

News | June 10, 2019

Aptinyx Reports Top-line Data from Phase 2 in Patients with Fibromyalgia

News | June 3, 2019

Carisma Therapeutics Names Dr. Robert Petit As Chief Scientific Officer

News | May 27, 2019

Carisma Therapeutics Featured in Nature Biotechnology’s Top Academic Spin-outs 2018

Press Release | May 14, 2019

Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer

Press Release | May 6, 2019

Skyhawk Therapeutics Announces Agreement with Takeda for Neurodegenerative Diseases

News | April 9, 2019

Pliant Therapeutics Reports Positive Results Of Phase 1 Clinical Study

News | March 1, 2019

Genome editing company Precision proposes $100M IPO

News | January 16, 2019

Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

Press Release | January 4, 2019

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

News | January 3, 2019

Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809